Product Code: A01389
Body extremities are external articulated organs, which perform different locomotive functions. Leading players are now specializing within the extremity reconstruction market because of the slow growth within the massive joint reconstruction market that features hips and knees. Although the extremities reconstruction market accounts for under a tiny low percentage of the orthopaedic industry, it is the fastest growing marketplace for reconstructive joint replacements.
The global extremity reconstruction market is driven by increase within the quantity of joint disorders such as osteoarthritis and arthritis, increase in the ageing population, and rapid rise in lifestyle related disorders such as obesity and diabetes, which further contribute to joint disorders. In addition, increase in awareness of patients about better treatment options and their desire for better quality of life is expected to further augment the expansion of the extremity reconstruction market.
Changes in clinical practice patterns and advancement of technologies such as reversed shoulder instead of anatomic shoulder, ankle arthroplasty procedure as an alternate to ankle fusion, and development of minimally invasive techniques such as stemless shoulder implants are further expected to drive the market. However, the high cost involved and potential failures and complications arising during and after surgeries are expected to restrain the expansion of the market.
The extremity reconstruction market is segmented by product, material, and geography. On the basis of product, the market is segmented mainly into upper extremity reconstruction and lower extremity reconstruction. The upper extremity reconstruction segment is further sub-segmented into shoulder, elbow, and hand & wrist. The lower extremity reconstruction segment is further segmented into foot & ankle.
Shoulder replacement accounted for the most important market share in 2020, owing to the large patient population, technological advancements in shoulder implants such stemless shoulder implants, and high adoption rates, particularly within the U.S. The ankle replacement market is anticipated to grow at the perfect rate during the forecast period, considering the wonderful clinical outcomes of the procedure.
On the basis of material, the market is segmented into metallic, ceramic, polymer, and natural materials. Metallic materials are extremely strong and are the favored choice of materials for joint replacement, which are expected to possess the best share within the market.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the simplest market share in 2020 followed by Europe. This massive share is primarily attributed to high adoption rate of technologically advanced products. Asia-Pacific is anticipated to witness the simplest rate of growth within the forecast period, primarily because of improving healthcare infrastructure and increase in awareness amongst patients. As the extremity reconstruction market is within the expansion phase, mergers and acquisitions are frequent during this market.
Key players in the market include, DePuy Synthes (a wholly-owned subsidiary of Johnson & Johnson), Stryker Corporation, Smith & Nephew plc., Integra Lifesciences Holdings Corporation, Exatech, Isto Biologics, Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skeletal Dynamics LLC.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the extremity reconstruction market share, segments, current trends, estimations, and dynamics of the extremity reconstruction market analysis from 2020 to 2030 to identify the prevailing extremity reconstruction market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the extremity reconstruction industry segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the extremity reconstruction industry.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global extremity reconstruction market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Upper Extremity
- Lower Extremity
By Material
- Metallic Material
- Ceramic Material
- Polymeric Material
- Natural Material
By Region
- North America
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Malaysia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Israel
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- CONMED Corp.
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- depuy synthes
- Integra LifeSciences Holdings Corporation
- Wright Medical Group N.V.
- Acumed, Inc.
- Arthrex, Inc
- Skeletal Dynamics LLC.
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Upper Extremity
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Lower Extremity
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
CHAPTER 5: EXTREMITY RECONSTRUCTION MARKET, BY MATERIAL
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Metallic Material
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Ceramic Material
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Polymeric Material
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Natural Material
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
CHAPTER 6: EXTREMITY RECONSTRUCTION MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Product
- 6.2.3 North America Market size and forecast, by Material
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Product
- 6.2.4.1.2 Market size and forecast, by Material
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Product
- 6.2.4.2.2 Market size and forecast, by Material
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Product
- 6.2.4.3.2 Market size and forecast, by Material
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Product
- 6.3.3 Europe Market size and forecast, by Material
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Product
- 6.3.4.1.2 Market size and forecast, by Material
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Product
- 6.3.4.2.2 Market size and forecast, by Material
- 6.3.4.3 U.K
- 6.3.4.3.1 Market size and forecast, by Product
- 6.3.4.3.2 Market size and forecast, by Material
- 6.3.4.4 Italy
- 6.3.4.4.1 Market size and forecast, by Product
- 6.3.4.4.2 Market size and forecast, by Material
- 6.3.4.5 Spain
- 6.3.4.5.1 Market size and forecast, by Product
- 6.3.4.5.2 Market size and forecast, by Material
- 6.3.4.6 Rest of Europe
- 6.3.4.6.1 Market size and forecast, by Product
- 6.3.4.6.2 Market size and forecast, by Material
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Product
- 6.4.3 Asia-Pacific Market size and forecast, by Material
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 Japan
- 6.4.4.1.1 Market size and forecast, by Product
- 6.4.4.1.2 Market size and forecast, by Material
- 6.4.4.2 China
- 6.4.4.2.1 Market size and forecast, by Product
- 6.4.4.2.2 Market size and forecast, by Material
- 6.4.4.3 India
- 6.4.4.3.1 Market size and forecast, by Product
- 6.4.4.3.2 Market size and forecast, by Material
- 6.4.4.4 South Korea
- 6.4.4.4.1 Market size and forecast, by Product
- 6.4.4.4.2 Market size and forecast, by Material
- 6.4.4.5 Malaysia
- 6.4.4.5.1 Market size and forecast, by Product
- 6.4.4.5.2 Market size and forecast, by Material
- 6.4.4.6 Rest of Asia-Pacific
- 6.4.4.6.1 Market size and forecast, by Product
- 6.4.4.6.2 Market size and forecast, by Material
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Product
- 6.5.3 LAMEA Market size and forecast, by Material
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Brazil
- 6.5.4.1.1 Market size and forecast, by Product
- 6.5.4.1.2 Market size and forecast, by Material
- 6.5.4.2 Israel
- 6.5.4.2.1 Market size and forecast, by Product
- 6.5.4.2.2 Market size and forecast, by Material
- 6.5.4.3 Saudi Arabia
- 6.5.4.3.1 Market size and forecast, by Product
- 6.5.4.3.2 Market size and forecast, by Material
- 6.5.4.4 South Africa
- 6.5.4.4.1 Market size and forecast, by Product
- 6.5.4.4.2 Market size and forecast, by Material
- 6.5.4.5 Rest of LAMEA
- 6.5.4.5.1 Market size and forecast, by Product
- 6.5.4.5.2 Market size and forecast, by Material
CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
CHAPTER 8: COMPANY PROFILES
- 8.1 CONMED Corp.
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 Smith & Nephew plc
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Stryker Corporation
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 Zimmer Biomet Holdings, Inc.
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 depuy synthes
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Integra LifeSciences Holdings Corporation
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 Wright Medical Group N.V.
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 Acumed, Inc.
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Arthrex, Inc
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 Skeletal Dynamics LLC.
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments